Impact and regulation of lambda interferon response in human metapneumovirus infection

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 730-742

  Baños Lara, Ma Del Rocío ^a   Harvey, Lindsey ^a   Mendoza, Alexander ^a   Simms, Dawn ^a   Chouljenko, Vladimir N ^a   Wakamatsu, Nobuko ^a   Gus Kousoulas, K ^a   Guerrero Plata, Antonieta ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INTERFERON LAMBDA 3; INTERFERON LAMBDA 4; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 28A; INTERLEUKIN 29; UNCLASSIFIED DRUG; IFNL4 PROTEIN, HUMAN; IL28A PROTEIN, HUMAN; IL28B PROTEIN, HUMAN; IL29 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RESPONSE; DISEASE SEVERITY; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFLAMMATION; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; VIRAL CLEARANCE; VIRUS LOAD; VIRUS RESISTANCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DISEASE MODEL; EPITHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; METAPNEUMOVIRUS; PARAMYXOVIRUS INFECTION; PATHOLOGY; VIROLOGY;

HUMAN METAPNEUMOVIRUS; MUS; PARAMYXOVIRIDAE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTOR-7; INTERLEUKINS; LUNG; METAPNEUMOVIRUS; MICE, INBRED BALB C; MICE, INBRED C57BL; PARAMYXOVIRIDAE INFECTIONS; VIRAL LOAD;

EID: 84919460199     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02897-14     Document Type: Article

References (55)

1. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7:719-724. http://dx.doi.org/10.1038/89098.
2. Deffrasnes C, Hamelin ME, Boivin G. 2007. Human metapneumovirus. Semin Respir Crit Care Med 28:213-221. http://dx.doi.org/10.1055/s-2007-976493.
3. Hermos CR, Vargas SO, McAdam AJ. 2010. Human metapneumovirus. Clin Lab Med 30:131-148. http://dx.doi.org/10.1016/j.cll.2009.10.002.
4. Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Bergeron MG, Dery P. 2003. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9:634-640. http://dx.doi.org/10.3201/eid0906.030017.
5. Mullins JA, Erdman DD, Weinberg GA, Edwards K, Hall CB, Walker FJ, Iwane M, Anderson LJ. 2004. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 10:700-705. http://dx.doi.org/10.3201/eid1004.030555.
6. van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD, Fouchier RA. 2003. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 188:1571-1577. http://dx.doi.org/10.1086/379200.
7. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350:443-450. http://dx.doi.org/10.1056/NEJMoa025472.
8. Kahn JS. 2006. Epidemiology of human metapneumovirus. Clin Microbiol Rev 19:546-557. http://dx.doi.org/10.1128/CMR.00014-06.
9. Leung J, Esper F, Weibel C, Kahn JS. 2005. Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 43:1213-1219. http://dx.doi.org/10.1128/JCM.43.3.1213-1219.2005.
10. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68. http://dx.doi.org/10.1038/ni873.
11. Donnelly RP, Kotenko SV. 2010. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 30:555-564. http://dx.doi.org/10.1089/jir.2010.0078.
12. Hamming OJ, Terczynska-Dyla E, Vieyres G, Dijkman R, Jorgensen SE, Akhtar H, Siupka P, Pietschmann T, Thiel V, Hartmann R. 2013. Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J 32:3055-3065. http://dx.doi.org/10.1038/emboj.2013.232.
13. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. 2013. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164-171. http://dx.doi.org/10.1038/ng.2521.
14. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer J A, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4:69-77. http://dx.doi.org/10.1038/ni875.
15. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M. 2005. Biological activity of interleukins-28 and-29: comparison with type I interferons. Cytokine 31:109-118. http://dx.doi.org/10.1016/j.cyto.2005.04.003.
16. Sommereyns C, Paul S, Staeheli P, Michiels T. 2008. IFN-lambda (IFNlambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017. http://dx.doi.org/10.1371/journal.ppat.1000017.
17. Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute SB, Garrigues U, Doyle S, Donnelly RP, Kotenko SV, Fitzgerald-Bocarsly P. 2012. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol 189:2735-2745. http://dx.doi.org/10.4049/jimmunol.1102038.
18. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, Falcone V, Sorgeloos F, Ehl S, Mayer D, Kochs G, Schwemmle M, Gunther S, Drosten C, Michiels T, Staeheli P. 2010. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84:5670-5677. http://dx.doi.org/10.1128/JVI.00272-10.
19. Mennechet FJ, Uze G. 2006. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107:4417-4423. http://dx.doi.org/10.1182/blood-2005-10-4129.
20. Hermant P, Demarez C, Mahlakoiv T, Staeheli P, Meuleman P, Michiels T. 2014. Human but not mouse hepatocytes respond to interferon-lambda in vivo. PLoS One 9:e87906. http://dx.doi.org/10.1371/journal.pone.0087906.
21. Baños-Lara Mdel R, Ghosh A, Guerrero-Plata A. 2013. Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 87:1242-1251. http://dx.doi.org/10.1128/JVI.01213-12.
22. Biacchesi S, Skiadopoulos MH, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321:247-259. http://dx.doi.org/10.1016/j.virol.2003.12.020.
23. Guerrero-Plata A, Baron S, Poast J S, Adegboyega PA, Casola A, Garofalo RP. 2005. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol 79:10190-10199. http://dx.doi.org/10.1128/JVI.79.16.10190-10199.2005.
24. Biacchesi S, Skiadopoulos MH, Yang L, Lamirande EW, Tran KC, Murphy BR, Collins PL, Buchholz UJ. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78:12877-12887. http://dx.doi.org/10.1128/JVI.78.23.12877-12887.2004.
25. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR. 1990. Product review. New mammalian expression vectors. Nature 348:91-92.
26. Buchholz UJ, Finke S, Conzelmann KK. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251-259.
27. Bao X, Liu T, Shan Y, Li K, Garofalo RP, Casola A. 2008. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog 4:e1000077. http://dx.doi.org/10.1371/journal.ppat.1000077.
28. Ueba O. 1978. Respiratory syncytial virus. I. Concentration and purification of the infectious virus. Acta Med Okayama 32:265-272.
29. Kisch AL, Johnson KM. 1963. A plaque assay for respiratory syncytial virus. Proc Soc Exp Biol Med 112:583. http://dx.doi.org/10.3181/00379727-112-28111.
30. Chakraborty K, Zhou Z, Wakamatsu N, Guerrero-Plata A. 2012. Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection. PLoS One 7:e37173. http://dx.doi.org/10.1371/journal.pone.0037173.
31. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http://dx.doi.org/10.1016/S1074-7613(00)00053-4.
32. Stack AM, Malley R, Saladino RA, Montana JB, MacDonald KL, Molrine DC. 2000. Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model. Vaccine 18:1412-1418. http://dx.doi.org/10.1016/S0264-410X(99)00399-0.
33. Graham BS, Bunton LA, Wright PF, Karzon DT. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88:1026-1033. http://dx.doi.org/10.1172/JCI115362.
34. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474-2485. http://dx.doi.org/10.4049/jimmunol.180.4.2474.
35. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. 2006. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80:4501-4509. http://dx.doi.org/10.1128/JVI.80.9.4501-4509.2006.
36. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, Staeheli P, Hornef MW. 2011. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA 108:7944-7949. http://dx.doi.org/10.1073/pnas.1100552108.
37. Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, Peeples ME, Garofalo RP. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol 34:320-329. http://dx.doi.org/10.1165/rcmb.2005-0287OC.
38. Guerrero-Plata A, Casola A, Garofalo RP. 2005. Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol 79:14992-14997. http://dx.doi.org/10.1128/JVI.79.23.14992-14997.2005.
39. Bao X, Liu T, Spetch L, Kolli D, Garofalo RP, Casola A. 2007. Airway epithelial cell response to human metapneumovirus infection. Virology 368:91-101. http://dx.doi.org/10.1016/j.virol.2007.06.023.
40. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451.
41. Miller DM, Klucher KM, Freeman J A, Hausman DF, Fontana D, Williams DE. 2009. Interferon lambda as a potential new therapeutic for hepatitis C. Ann N Y Acad Sci 1182:80-87. http://dx.doi.org/10.1111/j.1749-6632.2009.05241.x.
42. Friborg J, Levine S, Chen C, Sheaffer AK, Chaniewski S, Voss S, Lemm JA, McPhee F. 2013. Combinations of lambda interferon with directacting antiviral agents are highly efficient in suppressing hepatitis C virus replication. Antimicrob Agents Chemother 57:1312-1322. http://dx.doi.org/10.1128/AAC.02239-12.
43. Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ. 2009. Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages. J Virol 83:3834-3842. http://dx.doi.org/10.1128/JVI.01773-08.
44. Liu MQ, Zhou DJ, Wang X, Zhou W, Ye L, Li J L, Wang YZ, Ho WZ. 2012. IFN-lambda3 inhibits HIV infection of macrophages through the JAKSTAT pathway. PLoS One 7:e35902. http://dx.doi.org/10.1371/journal.pone.0035902.
45. Bartlett NW, Buttigieg K, Kotenko SV, Smith GL. 2005. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 86:1589-1596. http://dx.doi.org/10.1099/vir.0.80904-0.
46. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. http://dx.doi.org/10.1038/nature03464.
47. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179:3434-3442. http://dx.doi.org/10.4049/jimmunol.179.6.3434.
48. Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, Wack A. 2013. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog 9:e1003773. http://dx.doi.org/10.1371/journal.ppat.1003773.
49. Mordstein M, Kochs G, Dumoutier L, Renauld JC, Paludan SR, Klucher K, Staeheli P. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4:e1000151. http://dx.doi.org/10.1371/journal.ppat.1000151.
50. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD. 2010. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401:197-206. http://dx.doi.org/10.1016/j.virol.2010.02.022.
51. Mahlakõiv T, Ritz D, Mordstein M, DeDiego ML, Enjuanes L, Müller MA, Drosten C, Staeheli P. 2012. Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. J Gen Virol 93:2601-2605. http://dx.doi.org/10.1099/vir.0.046284-0.
52. Laham FR, Israele V, Casellas JM, Garcia AM, Lac Prugent CM, Hoffman SJ, Hauer D, Thumar B, Name MI, Pascual A, Taratutto N, Ishida MT, Balduzzi M, Maccarone M, Jackli S, Passarino R, Gaivironsky RA, Karron RA, Polack NR, Polack FP. 2004. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 189:2047-2056. http://dx.doi.org/10.1086/383350.
53. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79: 12608-12613. http://dx.doi.org/10.1128/JVI.79.19.12608-12613.2005.
54. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. 2004. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78:4363-4369. http://dx.doi.org/10.1128/JVI.78.8.4363-4369.2004.
55. Heinze B, Frey S, Mordstein M, Schmitt-Graff A, Ehl S, Buchholz UJ, Collins PL, Staeheli P, Krempl CD. 2011. Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo. J Virol 85:4071-4084. http://dx.doi.org/10.1128/JVI.01365-10.